T2340 |
AC1NS4RE
|
|
Tyrosinase
|
|
It is a tyrosine kinase inhibitor. |
T4428 |
CCT241736
|
|
Aurora Kinase
,
FLT
|
|
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resist... |
T6138 |
TCS 359
|
FLT3 Inhibitor |
FLT
|
|
TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM. |
T1938 |
FLT3-IN-2
|
|
FLT
|
|
FLT3-IN-2 is an FLT3 inhibitor (IC50<1 μM). |
T2272 |
BPR1J-097
|
BPR1J097 |
FLT
|
|
BPR1J-097 is a novel FLT-3 inhibitor(IC50: 11±7 nM) with promising in vivo anti-tumor activities. It also inhibits FLT-3... |
T11298 |
FLT3-IN-3
|
|
FLT
|
|
FLT3-IN-3 is an effective FLT3 inhibitor, and the IC50s of FLT3 WT and FLT3 D835Y are 13 and 8 nM, respectively. |
T6756 |
AMG 925
|
|
CDK
,
FLT
|
|
AMG 925 is a potent and orally bioavailable dual FLT3/CDK4 inhibitor with IC50 of 1 nM and 3 nM, respectively. |
T15335 |
FN-1501
|
|
FLT
,
CDK
|
|
FN-1501 is a potent FLT3 and CDK inhibitor (IC50s: 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK... |
T6020 |
Pacritinib
|
SB1518 |
FLT
,
Tyrosine Kinases
,
JAK
|
|
Pacritinib (SB1518) is an effective and specific inhibitor of JAK2 and FLT3 (IC50: 23/22 nM, in cell-free assays). |
T2640 |
Rebastinib
|
DCC 2036,DCC2036,DCC-2036 |
Apoptosis
,
Bcr-Abl
,
FLT
,
Src
|
|
DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 n... |
T7673 |
ATH686
|
ATH 686 |
FLT
,
Apoptosis
|
|
ATH 686 is an potent and selective Inhibitor of FLT3. |
T16144 |
MRX-2843
|
UNC2371 |
Others
,
FLT
|
|
MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively). |
T3065 |
TG101209
|
|
FLT
,
Apoptosis
,
Autophagy
,
JAK
,
c-RET
|
|
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM. |
T7007 |
UNC2025
|
UNC 2025,mrx-6313,UNC-2025 |
TAM Receptor
,
FLT
|
|
UNC-2025( IC50 of 0.74 nM and 0.8 nM) is a potent and orally bioavailable dual MER/FLT3 inhibitor. UNC-2025 is about 20-... |
T6174 |
R406
|
R-406 besylate |
Syk
,
Apoptosis
,
FLT
|
|
R406 is an effective Syk inhibitor (IC50: 41 nM) and shows no effects on Lyn. |
T8317 |
5'-Fluoroindirubinoxime
|
5'-FIO |
FLT
|
|
5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM). |
T3455 |
Merestinib
|
LY2801653 |
ROS Kinase
,
FLT
,
c-Met/HGFR
,
ROS
,
Discoidin Domain Receptor (DDR)
|
|
LY2801653 is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineo... |
T6115 |
Fostamatinib
|
R788 |
Monoamine Transporter
,
Syk
,
FLT
,
Adenosine Receptor
|
|
Fostamatinib(IC50 of 41 nM), which is a prodrug of the active metabolite R406, is a Syk inhibitor. It does not work on L... |
T6350 |
CHIR-124
|
CHIR 124,CHIR124 |
Chk
,
Apoptosis
,
PDGFR
,
FLT
,
Src
,
GSK-3
|
|
CHIR-124 is an effective Chk1 inhibitor (IC50: 0.3 nM). It has 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold... |
T2677 |
Crenolanib
|
CP-868596,ARO 002 |
Autophagy
,
FLT
,
PDGFR
|
|
Crenolanib is an orally bioavailable type III tyrosine kinases inhibitor of PDGFRα/β and FLT3 (IC50s: 11, 3.2, and 4 nM)... |